0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover0.00%IV--PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract Size--Options Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
undefined Stock Discussion
Under the asset purchase agreement, Bruker expects to acquire substantially all of the assets and rights associated with NanoString's business, including the nCounter(R) , GeoMx(R) , C...
$BiomX(PHGE.US)$ $Larimar Therapeutics(LRMR.US)$ $Clene(CLNN.US)$ $Glucotrack(GCTK.US)$ $Sonnet BioTherapeutic(SONN.US)$ $FibroBiologics(FBLG.US)$ $NanoString Technologies(NSTGQ.US)$
📊⚡️📊
No comment yet